How OCT Imaging Detects Wet AMD Early
Understanding Wet AMD and Why Early Detection Matters
Wet AMD is a serious eye condition that can cause rapid central vision loss if not caught and treated early. Understanding how it develops and why it can be silent in its early stages helps explain why advanced imaging like OCT is so essential.
Wet AMD occurs when abnormal, fragile blood vessels grow beneath the retina, which is the light-sensitive tissue lining the back of the eye. These vessels are prone to leaking fluid or blood into the macula, the small central area of the retina responsible for sharp, detailed vision. Even small amounts of leakage can damage the delicate cells you rely on for reading, driving, and recognizing faces.
Without treatment, wet AMD can cause severe central vision loss within weeks to months. It is a less common but far more aggressive form of macular degeneration than the dry type.
One of the greatest challenges with wet AMD is that damage can begin before you notice any change in your vision. Tiny amounts of fluid may leak from abnormal blood vessels and collect in or beneath the retina while your sight still seems completely normal. By the time symptoms like blurry or distorted central vision become obvious, significant and potentially irreversible damage may have already occurred.
This is exactly why routine screening with advanced imaging is so valuable. Finding the disease at its earliest stage gives treatment the best chance of preserving the vision you have.
Dry AMD is the more common form of macular degeneration. It involves the gradual thinning of the macula and the buildup of small deposits called drusen beneath the retina. Dry AMD usually progresses slowly over many years. Wet AMD is less common but can develop suddenly when abnormal blood vessels begin to grow and leak beneath the retina.
A person with dry AMD can convert to wet AMD at any point, which is why ongoing monitoring with OCT is critical even when your vision feels stable.
What OCT Imaging Is and How It Works
OCT is a non-invasive imaging technology that creates remarkably detailed pictures of your retina, allowing our specialists to see what a standard eye exam simply cannot reveal. It is painless, quick, and provides results immediately.
OCT stands for optical coherence tomography. It works by sending safe infrared light beams into the eye and measuring how that light reflects back from each layer of retinal tissue. A computer assembles those measurements into precise cross-sectional images of the retina, similar to how an MRI creates images of the body but using light instead of magnets. No radiation is involved.
A traditional eye exam or standard retinal photograph can only show the surface of the retina. OCT goes much deeper, revealing all the individual layers of the retina with extraordinary precision. It can measure retinal thickness and detect fluid hiding between layers, which is one of the earliest signs of wet AMD. This fluid appears on OCT scans as dark, swollen spaces between the normally compact retinal layers, even when the amount is far too small to cause any noticeable symptom.
An OCT scan is comfortable and requires no contact with your eye. You simply sit in front of the machine and rest your chin on a support while a beam of light scans your eye as you look at a small target. There are no flashes and no discomfort. Your pupils may be dilated beforehand to allow a clearer view, but the scan itself requires no eye drops. The entire process takes only a few minutes, and your results are available immediately for your specialist to review.
Who Should Have OCT Screening
Not everyone faces the same level of risk for wet AMD, but certain groups benefit most from regular OCT monitoring. Knowing whether you fall into a higher-risk category helps guide how often you should be screened.
Some people are significantly more likely to develop wet AMD and should discuss regular OCT screening with their eye care provider. The most important risk factors include:
- Age 65 or older, with risk increasing significantly after age 85
- A diagnosis of dry AMD, especially with large drusen or changes to the retinal pigment epithelium
- Advanced AMD already present in one eye
- A family history of macular degeneration
- Current or past smoking, which is a major risk factor
If any of these apply to you, ask your eye care provider whether OCT should be part of your regular exams.
People who already have dry AMD in one eye are at particularly elevated risk for developing wet AMD in the other eye. Research has shown that eyes with early, symptom-free abnormal blood vessel growth beneath the retina have a significantly higher likelihood of progressing to active, leaking disease within one year compared with eyes that do not have these early changes.
For anyone with a dry AMD diagnosis, OCT is not just a screening tool. It is an essential part of ongoing care that can detect a dangerous conversion before it causes lasting harm.
The right frequency for OCT monitoring depends on your individual risk level and findings. If you have been diagnosed with dry AMD, your specialist may recommend scans every few months to watch for early signs of conversion to wet AMD. If your risk is lower, annual imaging during a dilated eye exam may be appropriate. Your retina specialist will determine the schedule that is right for you based on your specific situation.
How OCT Detects Wet AMD at the Earliest Stage
OCT is uniquely capable of finding the early warning signs of wet AMD with a level of detail and sensitivity that no other standard test can match. Here is what it looks for and why those findings matter.
One of the earliest signs of wet AMD is fluid accumulating in or under the retina. OCT can detect fluid at three distinct levels: within the retinal layers (intraretinal fluid), beneath the retina (subretinal fluid), and beneath the retinal pigment epithelium, the thin supportive layer under the retina (sub-RPE fluid). Fluid at any of these levels suggests active wet AMD, and OCT can identify these changes weeks or even months before they affect your vision.
OCT can also reveal the formation of choroidal neovascular membranes, which are the abnormal blood vessels responsible for wet AMD. These membranes appear as irregular thickening beneath the retina on the scan. Identifying these structures early, sometimes before they have begun to leak, gives our specialists a critical head start in planning treatment. OCT has a very high detection rate for wet AMD, making it one of the most accurate diagnostic tools available for this condition.
One of the greatest strengths of OCT is its ability to compare scans taken at different visits side by side. Our specialists can measure even tiny changes in retinal thickness or detect new areas of fluid accumulation over time. This comparison helps determine whether your condition is stable, responding well to treatment, or showing early signs of worsening. It also helps guide decisions about how often treatment is needed, which benefits both your vision and your overall treatment experience.
What Happens After OCT Finds Signs of Wet AMD
When an OCT scan reveals fluid or abnormal vessel growth, the next steps are confirming the diagnosis and beginning treatment as quickly as possible. Acting early gives you the best chance of preserving your vision.
If your OCT scan reveals fluid or signs of abnormal blood vessel growth, your retina specialist may order additional tests to confirm the findings and plan treatment. Fluorescein angiography uses a special dye and a camera to photograph blood flow in the retina, showing exactly where vessels may be leaking. OCT angiography is a newer technique that maps blood flow through the retina without dye. Together, these tests give our specialists a complete picture of your condition.
The primary treatment for wet AMD is anti-VEGF therapy. VEGF, or vascular endothelial growth factor, is a protein that signals the body to grow new blood vessels. In wet AMD, this process goes into overdrive and creates the abnormal, leaking vessels that damage the retina. Anti-VEGF medications are injected directly into the eye (called intravitreal injections) to block this protein, reduce leakage, and help stabilize or improve vision. Several anti-VEGF options are currently available, including:
- Eylea (aflibercept), typically given every 4 to 8 weeks after an initial loading phase
- Eylea HD (high-dose aflibercept), given monthly for 3 months followed by every 8 to 16 weeks
- Lucentis (ranibizumab), one of the first anti-VEGF medications approved for wet AMD, given every 4 weeks
- Avastin (bevacizumab), used off-label for wet AMD, typically every 4 to 6 weeks
- Vabysmo (faricimab), a bispecific antibody that targets two pathways and can be given every 4 to 16 weeks
Your retina specialist will recommend the medication and schedule that fits your individual needs and response to treatment.
Once treatment begins, OCT becomes the primary tool for monitoring how well the medication is working. Your specialist will perform OCT scans at each visit to check whether fluid has resolved, remained stable, or returned. Many retina specialists use a treat-and-extend approach, where the time between injections is gradually lengthened as long as the disease stays under control. OCT findings at every visit guide these decisions, helping to maintain your vision with the least frequent treatment possible.
Advances in OCT and AMD Monitoring
The technology used to monitor and treat wet AMD continues to advance rapidly. Staying informed about these developments helps you understand the full range of options available now and in the near future.
One of the most exciting emerging developments in retina care is home OCT monitoring. The Notal Vision Home OCT system is a device designed for daily self-imaging in patients with wet AMD. Patients perform daily scans at home, and the data is automatically uploaded and analyzed by artificial intelligence algorithms. This approach is being studied for its potential to detect disease reactivation between office visits earlier than standard monitoring alone. The device is currently undergoing evaluation for potential regulatory approval.
While anti-VEGF therapy remains the standard of care for wet AMD, the treatment landscape continues to evolve. Ongoing research into new delivery methods, longer-lasting medications, and gene therapy approaches aims to reduce the frequency of injections and improve outcomes for patients with all forms of AMD. Your retina specialist can discuss which current and emerging options may be relevant to your care.
Living Well with a Wet AMD Diagnosis
A wet AMD diagnosis requires ongoing attention, but there are meaningful steps you can take between appointments to support your eye health and your overall well-being. Being an active participant in your own care makes a real difference.
Between appointments, an Amsler grid can help you watch for early changes in your central vision. This simple tool looks like a sheet of graph paper with a dot in the center. Covering one eye at a time and focusing on the dot, you look for any wavy lines, missing areas, or blank spots that were not there before. If you notice any new changes, contact your retina specialist promptly. Home monitoring supplements your OCT scans but does not replace them.
While no lifestyle change can reverse wet AMD, certain habits may help support overall retinal health and reduce the risk of progression. Steps commonly recommended for AMD patients include:
- Not smoking, as smoking significantly increases AMD risk and can accelerate its progression
- Eating a diet rich in leafy greens, fish, and colorful fruits and vegetables
- Maintaining a healthy weight and staying physically active
- Wearing sunglasses that block ultraviolet light
- Taking AREDS2 supplements if your retina specialist recommends them for your specific situation
Receiving a wet AMD diagnosis can feel overwhelming, and it is completely normal to have concerns about your vision and your future. Many patients find real comfort and practical help through low-vision rehabilitation services, support groups, and counseling. Our team can connect you with resources designed to help you adapt to vision changes and maintain the best possible quality of life throughout your treatment.
When to See a Specialist Right Away
Knowing which symptoms require urgent attention can make a critical difference in your outcome. Some changes in vision need to be evaluated the same day they occur.
If you experience any of the following symptoms, contact a retina specialist or go to an emergency eye care provider immediately. These symptoms can signal sudden, serious changes that require prompt evaluation:
- A sudden increase in floaters in your vision
- Flashes of light in one or both eyes
- A curtain or shadow appearing across any part of your vision
- Sudden loss of vision in one eye
- New or worsening distortion, especially straight lines appearing bent or wavy
- A dark or blank spot appearing in the center of your vision
Do not wait to see whether these symptoms improve on their own. Same-day evaluation is strongly recommended.
Even without any symptoms, regular eye exams that include OCT imaging are essential if you are at risk for wet AMD. An optometrist or general ophthalmologist can screen for early AMD signs and refer you to a retina specialist when needed. If you are over 65, have a family history of AMD, or have already been diagnosed with dry AMD, ask your eye care provider whether OCT should be a regular part of your eye care routine. Early detection through OCT remains one of the most effective ways we have to preserve your vision long term.
Frequently Asked Questions
Here are answers to some of the questions we hear most often about OCT imaging and wet AMD care.
OCT is completely safe for repeated use. It relies on infrared light, not radiation, and never makes contact with your eye. There is no limit on how often it can be performed. During active treatment for wet AMD, your specialist may order a scan at every visit, while patients in a stable phase may be scanned less frequently. You can have as many OCT scans as your care requires without any risk to your eyes or your health.
Yes, and this is one of its most important advantages. OCT can reveal very small amounts of fluid beneath or within the retinal layers and early abnormal blood vessel growth long before these changes affect your sight. For high-risk patients, this means treatment can begin at the earliest possible moment, giving you the greatest chance of preserving your current level of vision. Waiting until symptoms appear significantly narrows the window for effective intervention.
A dilated eye exam allows your provider to examine the surface of the retina and spot obvious changes. OCT goes several steps further by creating precise cross-sectional images of all the retinal layers, measuring retinal thickness, and detecting fluid or structural changes invisible to the naked eye or standard photography. Think of it like the difference between looking at the outside of a building and seeing a detailed architectural diagram of every floor inside. Both exams matter, but OCT provides information that standard examination cannot.
In most cases, yes. When OCT reveals active fluid from abnormal blood vessels, prompt treatment is recommended to stop further damage and protect your vision. Waiting, even briefly, can allow additional retinal cells to be harmed. Treatment typically begins with a series of monthly injections during a loading phase, after which the schedule is adjusted based on how your eye responds. Starting treatment early, before significant vision loss has occurred, consistently leads to better outcomes.
For most patients, yes. Wet AMD is a chronic condition, and OCT is the primary tool for monitoring it over the long term. Even when the disease appears stable, regular scans are important because wet AMD can reactivate after periods of remission, sometimes with no warning symptoms. The frequency of scanning may decrease during well-controlled phases, but routine monitoring is generally a lifelong part of wet AMD management rather than something that ends once treatment is underway.
Contact your retina specialist promptly rather than waiting for your next scheduled visit. Sudden or new changes in your central vision, such as new distortion, a dark spot, or blurring that was not there before, can indicate that wet AMD has become active or has reactivated. Using an Amsler grid at home each day helps you identify these changes early. If you are unsure whether a change is significant, it is always safer to call and ask than to wait and see.
Schedule Your OCT Exam at Associated Eye Physicians & Surgeons
Our team at Associated Eye Physicians & Surgeons is dedicated to protecting the vision of patients across New Jersey using the most advanced diagnostic technology available, including OCT imaging for early detection and ongoing management of wet AMD. Whether you have been recently diagnosed, are monitoring dry AMD, or simply want a thorough retinal evaluation, we are here to provide expert, compassionate care every step of the way. We encourage you to reach out and schedule your comprehensive eye exam so we can help you keep your vision as strong as possible for years to come.
I think I may have seen every doctor and nurse over the years, and they all make me feel very secure in their hands. With my cataract surgeries, Dr. Hosler is the best!
Steven Thornburg
Everyone was helpful and courteous. I always recommend this practice to persons looking for an excellent eye care.
Benedict Emanuele
Helpful and friendly receptionist and technicians. Great doctor and excellent care.
Deborah W
Dr.Khan is my doctor. He is awesome. Checks my eyes on yearly bases & does my BOTOX injections in office 😎 hands down won’t regret him
Mimi Duran
very happy with the service looking forward to my next visit
Jim Bogar